Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

A compound found in python blood could lead to a new kind of weight loss drug, one that suppresses appetite without some of ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...

Part of the controversy surrounding weight loss drugs like Ozempic and Mounjaro involve their side effects.

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic ...

Up to now, GLP-1 medications have had a stranglehold on the pharmaceutical market, with hundreds more in the works. But ...

FIRST ON FOX: The Food and Drug Administration (FDA) rolled out a new platform, backed by artificial intelligence, that will streamline publicly accessible reporting of negative or unexpected health ...

Those days and weeks after a hospitalization are often a demanding, sometimes confusing time for patients, their loved ones ...